Insider Selling: Paysign, Inc. (NASDAQ:PAYS) Insider Sells $765,228.97 in Stock

Paysign, Inc. (NASDAQ:PAYSGet Free Report) insider Topline Capital Management, Ll sold 231,187 shares of the firm’s stock in a transaction that occurred on Friday, December 27th. The stock was sold at an average price of $3.31, for a total transaction of $765,228.97. Following the completion of the transaction, the insider now directly owns 5,859,046 shares in the company, valued at $19,393,442.26. This trade represents a 3.80 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Topline Capital Management, Ll also recently made the following trade(s):

  • On Monday, December 30th, Topline Capital Management, Ll sold 227,084 shares of Paysign stock. The shares were sold at an average price of $3.07, for a total value of $697,147.88.

Paysign Trading Down 5.3 %

PAYS stock opened at $2.86 on Friday. The company has a market capitalization of $153.15 million, a PE ratio of 19.07 and a beta of 0.93. The business’s fifty day moving average price is $3.38 and its 200 day moving average price is $4.00. Paysign, Inc. has a 12-month low of $2.40 and a 12-month high of $5.59.

Paysign (NASDAQ:PAYSGet Free Report) last released its earnings results on Tuesday, November 5th. The company reported $0.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.01 by $0.02. The company had revenue of $15.26 million for the quarter, compared to analyst estimates of $14.96 million. Paysign had a net margin of 14.28% and a return on equity of 30.64%. During the same period in the prior year, the business earned $0.02 EPS. Research analysts predict that Paysign, Inc. will post 0.21 EPS for the current fiscal year.

Hedge Funds Weigh In On Paysign

Several hedge funds and other institutional investors have recently made changes to their positions in PAYS. Renaissance Technologies LLC lifted its stake in Paysign by 25.0% in the second quarter. Renaissance Technologies LLC now owns 1,504,380 shares of the company’s stock worth $6,484,000 after acquiring an additional 301,000 shares during the last quarter. Royce & Associates LP purchased a new stake in shares of Paysign during the 3rd quarter worth $814,000. Rhumbline Advisers grew its stake in shares of Paysign by 25.1% during the second quarter. Rhumbline Advisers now owns 35,835 shares of the company’s stock worth $154,000 after purchasing an additional 7,190 shares in the last quarter. Joule Financial LLC acquired a new position in shares of Paysign during the third quarter worth $1,478,000. Finally, BNP Paribas Financial Markets increased its holdings in Paysign by 257.0% in the third quarter. BNP Paribas Financial Markets now owns 44,793 shares of the company’s stock valued at $164,000 after buying an additional 32,245 shares during the last quarter. Hedge funds and other institutional investors own 25.89% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. Lake Street Capital began coverage on shares of Paysign in a report on Friday, December 20th. They issued a “buy” rating and a $6.00 price objective for the company. Barrington Research reaffirmed an “outperform” rating and issued a $7.00 target price on shares of Paysign in a research report on Monday, November 4th. Four research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $6.13.

View Our Latest Report on PAYS

About Paysign

(Get Free Report)

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.

See Also

Insider Buying and Selling by Quarter for Paysign (NASDAQ:PAYS)

Receive News & Ratings for Paysign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paysign and related companies with MarketBeat.com's FREE daily email newsletter.